Manduzio Palma
Diagnostic Department, Immunohematology and Transfusion Medicine, Policlinico Riuniti, Via Pinto 1, 71122 Foggia, Italy.
Hematol Rep. 2024 Dec 17;16(4):815-824. doi: 10.3390/hematolrep16040077.
Red blood cell (RBC) alloimmunization and antibodies formation against non-self antigens on red cells may occur after blood transfusion, pregnancies or other exposures. The RBC alloimmunization rate varies from 2% to 6% according to recent studies. The antibody screen is performed to identify or confirm the presence of antibodies in patient's serum or plasma, as a preoperative or pretransfusion test. The antibody identification process and major crossmatch are critical steps of risk management in transfusion medicine. The aim of this article is to describe a flow chart of the antibody identification. I report three educational examples of case studies associated with the negative direct antiglobulin test and clinically significant single and multiple alloantibodies using the gel method, Anti-M, Anti-c and Anti-E, Anti-Jka and Anti-s. Furthermore, I provide a critical analysis of the current literature on the topic. The flow chart of the antibody identification may simplify the process and possibly reduce errors in routine workflow.
输血、妊娠或其他接触后,可能会发生红细胞(RBC)同种免疫以及针对红细胞上非自身抗原的抗体形成。根据最近的研究,RBC同种免疫率在2%至6%之间。作为术前或输血前检查,进行抗体筛查以识别或确认患者血清或血浆中抗体的存在。抗体鉴定过程和主交叉配血是输血医学风险管理的关键步骤。本文的目的是描述抗体鉴定的流程图。我报告了三个教育案例研究实例,这些案例使用凝胶法检测抗-M、抗-c和抗-E、抗-Jka和抗-s,涉及阴性直接抗球蛋白试验以及具有临床意义的单一和多种同种抗体。此外,我对该主题的当前文献进行了批判性分析。抗体鉴定流程图可能会简化该过程,并有可能减少常规工作流程中的错误。